Intelligent Bio Solutions's quarterly market cap
increased
from Sep. 2025 ($9.28 Mil) to Dec. 2025 ($11.80 Mil) but then
declined
from Dec. 2025 ($11.80 Mil) to Mar. 2026 ($6.69 Mil).
Intelligent Bio Solutions's annual market cap
increased
from Jun. 2023 ($6.34 Mil) to Jun. 2024 ($6.64 Mil) and
increased
from Jun. 2024 ($6.64 Mil) to Jun. 2025 ($12.59 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Intelligent Bio Solutions's Enterprise Value for Today is $0.16 Mil.
Intelligent Bio Solutions (NAS:INBS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Intelligent Bio Solutions Market Cap Related Terms
Intelligent Bio Solutions Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Intelligent Bio Solutions's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intelligent Bio Solutions Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Intelligent Bio Solutions's Market Cap distribution charts can be found below:
* The bar in red indicates where Intelligent Bio Solutions's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intelligent Bio Solutions (INBS) has a Market Cap of $5.38 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Intelligent Bio Solutions and its competitors. According to the industry distribution chart, Intelligent Bio Solutions ranks #792 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 91.5%.
Is Intelligent Bio Solutions' Market Cap too high?
Intelligent Bio Solutions' current Market Cap is $5.38 Mil. The Medical Devices & Instruments industry median Market Cap is 121.29. Intelligent Bio Solutions' value of $5.38 Mil is 95.6% below this industry median. Based on the distribution chart, Intelligent Bio Solutions ranks #792 out of 866 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Intelligent Bio Solutions has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Intelligent Bio Solutions' Market Cap compare to RBOT and XAIR?
According to the Medical Devices & Instruments industry distribution chart, Intelligent Bio Solutions ranks #792 out of 866 companies for Market Cap. This places Intelligent Bio Solutions in the lower half of its industry. The industry median Market Cap is 121.29. Intelligent Bio Solutions' value of $5.38 Mil is 95.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.29, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Intelligent Bio Solutions's current Market Cap of $5.38 Mil is 95.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Intelligent Bio Solutions and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Intelligent Bio Solutions's current Market Cap is $5.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intelligent Bio Solutions stock overvalued right now?
Based on GuruFocus' analysis, Intelligent Bio Solutions (INBS) is currently considered Possible Value Trap. The stock's GF Value™ is $3.93, compared to a current price of $2.25 — trading 42.7% below its estimated fair value. The current Market Cap is $5.38 Mil and 95.6% below the Medical Devices & Instruments industry median of 121.29. Intelligent Bio Solutions' overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Intelligent Bio Solutions (INBS), the current Market Cap is $5.38 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Intelligent Bio Solutions (INBS) Overvalued in 2026?
Based on GuruFocus' analysis, Intelligent Bio Solutions stock appears to be undervalued.
The current stock price of $2.25 is trading 42.7% below its estimated GF Value™ of $3.93.
GuruFocus considers Intelligent Bio Solutions to be Possible Value Trap.
Key valuation signals for INBS:
Market Cap: $5.38 Mil
GF Value™: $3.93 vs. price of $2.25 (42.7% below fair value)
Industry Position: 95.6% below the Medical Devices & Instruments median (#792 of 866)
No single metric tells the full story. See the INBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
46GF Score
Get the complete analysis for INBS
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INBS has been successfully added to your 
